The Metabolic Nutritionist

Cancer Resistance and Interventions to Mitigate Resistance – Part 1

The post outlines how multi‑agent metabolic regimens—using repurposed drugs and nutraceuticals—initially suppress tumors but often trigger adaptive resistance after about two years. Resistance arises from metabolic plasticity, enrichment of cancer‑stem‑cell‑like subpopulations, and rewiring of stress‑signaling pathways. The author proposes press‑pulse, drug‑rotation, and targeted CSC strategies to prevent or delay this evolutionary escape. Practical examples include alternating doxycycline and mebendazole and integrating intermittent high‑intensity pulses with chronic low‑dose backbones.